Cargando…
Prostate Cancer Imaging and Biomarkers Guiding Safe Selection of Active Surveillance
BACKGROUND: Active surveillance (AS) is a widely adopted strategy to monitor men with low-risk, localized prostate cancer (PCa). Current AS inclusion criteria may misclassify as many as one in four patients. The advent of multiparametric magnetic resonance imaging (mpMRI) and novel PCa biomarkers ma...
Autores principales: | Glaser, Zachary A., Gordetsky, Jennifer B., Porter, Kristin K., Varambally, Sooryanarayana, Rais-Bahrami, Soroush |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670116/ https://www.ncbi.nlm.nih.gov/pubmed/29164056 http://dx.doi.org/10.3389/fonc.2017.00256 |
Ejemplares similares
-
MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence
por: Glaser, Zachary A., et al.
Publicado: (2018) -
Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification
por: Gennaro, Kyle H., et al.
Publicado: (2018) -
Personalized prostate cancer care
por: Rais-Bahrami, Soroush, et al.
Publicado: (2018) -
Prostatic intraepithelial neoplasia-like ductal prostatic adenocarcinoma: A case suitable for active surveillance?
por: Rais-Bahrami, Soroush, et al.
Publicado: (2017) -
Detection of extraprostatic disease and seminal vesicle invasion in patients undergoing magnetic resonance imaging-targeted prostate biopsies
por: Baumgartner, Erin M., et al.
Publicado: (2018)